secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2026-08-17T12:30:36+00:00
Accession:  0001493152-26-038647
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata raises $3.4M in private placement of shares and warrants
----------------------------------------------------------------

- Gross proceeds ~$3.4M; net ~$3.2M after expenses; closing expected Aug 18, 2026.
- Issued 2,293,608 shares (or pre-funded warrants) plus series E and F warrants for 2,293,608 shares each at $1.46.
- Insiders (CEO, CFO, management) bought ~4.9M shares/warrants for ~$2.4M at $1.47 per unit.
- Warrants exercisable at $1.46; series E expire 5 years, series F expire 24 months from stockholder approval; potential $6.7M if exercised.
- Proceeds for general corporate purposes, including OTC acne kit launch and R&D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226038647/0001493152-26-038647-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226038647/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-038647

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer